Faster-acting insulin aspart improves postprandial glycaemia versus insulin aspart in patients with type 1 diabetes mellitus

被引：0
|
作者：
Heise, T. [1 ]
Haahr, H. [2 ]
Jensen, L. [2 ]
Erichsen, L. [2 ]
Hompesch, M. [3 ]
机构：
[1] Profil, Neuss, Germany
[2] Novo Nordisk AS, Soborg, Denmark
[3] Profil Inst Clin Res Inc, Chula Vista, CA USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
120
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [31] Sensor-derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster-acting insulin aspart or insulin aspart: a secondary analysis of the CopenFast trial
    Soholm, J. C.
    Norgaard, S. K.
    Norgaard, K.
    Clausen, T. D.
    Damm, P.
    Mathiesen, E.
    Ringholm, L.
    DIABETOLOGIA, 2024, 67 : S229 - S229
  • [32] Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
    Hanne Haahr
    Thomas R. Pieber
    Chantal Mathieu
    Theis Gondolf
    Masanari Shiramoto
    Lars Erichsen
    Tim Heise
    Clinical Pharmacokinetics, 2019, 58 : 639 - 649
  • [33] Postprandial Glucose Control Using the Medtronic Advanced Hybrid Closed-Loop System: Faster-Acting Insulin Aspart vs. Insulin Aspart
    Lee, Melissa H.
    Vogrin, Sara
    Paldus, Barbora
    Morrison, Dale
    Zaharieva, Dessi
    Lu, Jean
    Jones, Hannah
    Wyatt, Sue A.
    Netzer, Emma
    Sims, Catriona M.
    Macisaac, Richard
    Grosman, Benyamin
    Roy, Anirban
    Kurtz, Natalie
    Jenkins, Alicia
    Oneal, David N.
    DIABETES, 2020, 69
  • [34] Higher early insulin exposure and greater early glucose-lowering effect with faster-acting insulin aspart vs insulin aspart in elderly and younger adults with type 1 diabetes
    Hovelmann, U.
    Zijlstra, E.
    Stender-Petersen, K.
    Jacobsen, J. B.
    Heise, T.
    Haahr, H.
    DIABETOLOGIA, 2015, 58 : S450 - S450
  • [35] Faster-acting insulin aspart reduces glycaemic variability in sensor-augmented pump treated type 1 diabetes patients
    Moreno-Fernandez, Jesus
    Garcia-Seco, Jose Alberto
    Virlaboa-Cebrian, Rita
    Seco, Angela Maria
    Munoz-Rodriquez, Jose Ramon
    Gomez-Romero, Francisco Javier
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2023, 70 (06): : 389 - 395
  • [36] Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes
    Bowering, K.
    Harvey, J.
    Kolaczynski, J. W.
    Snyder, J. W.
    Bode, B. W.
    DIABETIC MEDICINE, 2019, 36 (06) : 771 - 775
  • [37] Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart
    Heise, T.
    Hoevelmann, U.
    Brondsted, L.
    Adrian, C. L.
    Nosek, L.
    Haahr, H.
    DIABETES OBESITY & METABOLISM, 2015, 17 (07): : 682 - 688
  • [38] Effectiveness of Faster Aspart versus Insulin Aspart in Children with Type 1 Diabetes: A Meta-Analysis
    Wei, Jie
    Wang, Yueer
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (01) : 23 - 34
  • [39] Fast-Acting Insulin aspart (faster aspart) - Clinical Data on Application in Type 1 and 2 Diabetes
    Jaeckel, E.
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (06): : 313 - 319
  • [40] Comparison of faster-acting aspart with insulin aspart under conditions mimicking underestimation or missed meal boluses in type 1 diabetes using closed-loop insulin delivery
    Thabit, Hood
    Mubita, Womba
    Rubio, Jose
    Karuppan, Mini
    Schofield, Jonathan
    Willinska, Malgorzata E.
    Hovorka, Roman
    Leelarathna, Lalantha
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1121 - 1124
12345